Livzon Pharmaceutical Group Inc.

Ticker

1513.HK

ISIN

-

Price

HKD 29.50

Change Today

+0.12 / 0.408 %

Price 1 year ago

29.98 / -1.601 %

Market Capitalization

28,954,742,784.00

52 Week Low

28.90

52 Week High

30.10

200 Day Moving Average

29.51

50-day Moving Average

29.51


Price evolution

Yearly Returns


Peers


Peers

Company information

Summary

Livzon Pharmaceutical Group Inc. engages in the research, development, production, and sale of pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People's Republic of China. The company offers Ilaprazole enteric coated tablets for the treatment of duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection; Urofollitropin for injection to treat anovulation and sufferers; Perospirone Hydrochloride for the treatment of schizophrenia; Anti-viral Granules to treat upper respiratory tract infection and influenza; and Shenqi Fuzheng Injection for the treatment of weakness and tiredness, lassitude, spontaneous sweating, and vertigo, as well as for the patients of lung and stomach cancer. It also offers diagnostic reagents, such as diagnostic kit for IgM/IgG antibody to coronavirus; nucleic acid test kit for human immunodeficiency virus type 1; antinuclear antibody test kits; interferon-gamma release assays test kits; and rapid test for mycoplasma pneumoniae IgM antibody. In addition, the company provides biochemical drugs, microbiological preparations, biologic products, Chinese drug preparations and pharmaceutical raw materials, and antibiotics. It also exports its products. The company was founded in 1985 and is headquartered in Zhuhai, China.

Sector

Healthcare

Industry

Drug Manufacturers—Specialty & Generic

Country

China

Exchange

HKG

Earnings Per Share

-

P/E Ratio

-

Debt/Equity Ratio

20.458

Beta

0.616834

City

Zhuhai

Address

Headquarters Building

Zip

519090

Website

https://www.livzon.com.cn

Ebitda

2,348,527,872.00

Ebitda Margins

0.19

Enterprise to Ebitda

6.90

Enterprise Value

16,202,428,416.00

Target Price

36.27

Estimated Price

-

Book Value

13.43

Expected Growth

-

Balance sheet

Income statement

Sustainability

Correlation

CompanyNameCorrelation
TLRYTilray Brands, Inc. - Class 2-0.05
CGCCanopy Growth Corporation0.06
TEVATeva Pharmaceutical Industries0.27
0570.HKTRAD CHI MED0.36

Similar companies

TickerNameCityCountryCurrencyExchangeBetaEV/EBITDAEmployeesSite
MCOAMARIJUANA COMPANY OF AMERICA INLos AngelesUnited StatesUSDPNK1.15-1.917https://www.marijuanacompanyofamerica.com
600277.SSELION CLEAN ENERGY CO LTDBeijingChinaCNYSHH0.8114.083926https://www.elion.cn
300026.SZTIANJIN CHASE SUNTianjinChinaCNYSHZ-0.1016.16https://www.chasesun.cn
ENDPEndo International plcDublinIrelandUSDNMS1.129.593103https://www.endo.com
300110.SZHUAREN PHARMACEUTIQingdaoChinaCNYSHZ0.8622.142242https://www.qdhuaren.com
600518.SSKANGMEI PHARMACEUTICAL CO LTDPuningChinaCNYSHH0.26-11.186410https://www.kangmei.com.cn
600062.SSCHINA RESOURCES DOUBLE-CRANE PHBeijingChinaCNYSHH-0.1612.2111029https://www.dcpc.com
600079.SSHUMANWELL HEALTHCARE (GROUP) COWuhanChinaCNYSHH0.8713.3215746https://www.humanwell.com.cn
SIDO.JKIndustri Jamu dan Farmasi SidoSemarangIndonesiaIDRJKT0.1415.043081https://www.sidomuncul.co.id
600196.SSSHANGHAI FOSUN PHARMACEUTICAL GShanghaiChinaCNYSHH0.6530.5936279https://www.fosunpharma.com
HLN.LHALEON PLCWeybridgeUnited KingdomGBpLSE16.3122000https://www.haleon.com
002001.SZZHEJIANG NHU COXinchangChinaCNYSHZ0.3110.4510805https://www.cnhu.com
0460.HKSIHUAN PHARMWan ChaiHong KongHKDHKG0.617.154282https://www.sihuanpharm.com
TLRYTilray Brands, Inc. - Class 2LeamingtonCanadaUSDNMS-28.58https://www.tilray.com
300199.SZHYBIO PHARMACEUTICShenzhenChinaCNYSHZ0.02-117.98885https://www.hybio.com.cn
0570.HKTRAD CHI MEDWan ChaiHong KongHKDHKG0.515.9717098https://www.china-tcm.com.cn
600216.SSZHEJIANG MEDICINEShaoxingChinaCNYSHH-0.167.755901https://www.zmc.top
300194.SZFUAN PHARMACEUTICAChongqingChinaCNYSHZ0.4115.823004https://www.fapharm.com
300039.SZSHANGHAI KAIBAO PHShanghaiChinaCNYSHZ0.3132.281432https://www.xykb.com
300142.SZWALVAX BIOTECHNOLOKunmingChinaCNYSHZ0.6256.64https://www.walvax.com
300239.SZBAOTOU DONGBAO BIOBaotouChinaCNYSHZ0.2643.881354https://www.dongbaoshengwu.com
600252.SSGUANGXI WUZHOU ZHONGHENG GROUPWuzhouChinaCNYSHH0.3956.883453https://www.wz-zhongheng.com
300158.SZSHANXI ZHENDONG PHChangzhiChinaCNYSHZ0.325.064123https://www.zdjt.com
600781.SSFUREN GROUP PHARMACEUTICAL CO LShanghaiChinaCNYSHH0.27-5.142916https://www.shfuren.cn
ZOMZomedica Corp.Ann ArborUnited StatesUSDASE0.59-3.1047https://www.zomedica.com
300534.SZGANSU LONGSHENRONGLanzhouChinaCNYSHZ0.38195.38302https://www.lsrfzy.com
SFLMSFLMAVEN CORPLeamington SpaUnited KingdomUSDPNK3.15-1.481https://www.dnadynamicsinc.com
600750.SSJIANGXI JIANGZHONG PHARMACEUTICNanchangChinaCNYSHH0.409.254153https://www.jzjt.com
600380.SSJOINCARE PHARMACEUTICAL GROUP IShenzhenChinaCNYSHH0.666.0713234https://www.joincare.com
TEVATeva Pharmaceutical IndustriesTel AvivIsraelUSDNYQ1.227.4534713https://www.tevapharm.com
600521.SSZHEJIANG HUAHAI PHARMACEUTICALLinhaiChinaCNYSHH0.2230.807019https://www.huahaipharm.com
600664.SSHARBIN PHARMACEUTICAL GROUP COHarbinChinaCNYSHH9.55https://www.hayao.com
300401.SZZHEJIANG GARDEN BIDongyangChinaCNYSHZ-0.2414.95742https://www.hybiotech.com
600568.SSZHONG ZHU HEALTHCARE HOLDING COZhuhaiChinaCNYSHH0.45-231.661286https://www.zz600568.com
CGCCanopy Growth CorporationSmiths FallsCanadaUSDNMS2.23-2.613151https://www.canopygrowth.com
DVLPGOLDEN DEVELOPING SOLUTIONS INCFort LauderdaleUnited StatesUSDPNK1.60https://goldendeveloping.com
SIGASIGA Technologies Inc.New YorkUnited StatesUSDNGM0.4012.1339https://www.siga.com
3320.HKCHINARES PHARMAWan ChaiHong KongHKDHKG0.429.5265000https://www.crpharm.com
300601.SZSHENZHEN KANGTAI BShenzhenChinaCNYSHZ0.3117.712445https://www.biokangtai.com
600267.SSZHEJIANG HISUN PHARMACEUTICAL CTaizhouChinaCNYSHH0.5311.178280https://www.hisunpharm.com

Funds


Mutual Fund Holders

Social

Dividends

Ratings

News

Earnings

SEC Filings

Options

Indicators

Glossary
Momentum
A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend.
Inertia
In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend.
Relative Strength Index (RSI)
A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction.
Fibonacci's Weighted Moving Average
A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend.
Williams %R
A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce.
Relative Volatility Index (RVI)
A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk.
Commodity Channel Index (CCI)
A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.